Skip to content
  • Saturday, 15 August 2026
  • 3:06 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Sex Differences in Modifiable Risk Factors of Dementia and Their Associations with Cognition
Neuroscience & Brain Research

Sex Differences in Modifiable Risk Factors of Dementia and Their Associations with Cognition

Rifan Muazin Jun 4, 2026 0

The University of California San Diego School of Medicine has released a landmark study identifying that women are not only…

Read More
Neuroscience & Brain Research

Sex Differences in Modifiable Risk Factors of Dementia and Their Associations with Cognition

Rifan Muazin May 28, 2026 0

The landscape of neurodegenerative research underwent a significant shift on May 19, 2026, as scientists at the University of California…

Read More
Neuroscience & Brain Research

Sex Differences in Modifiable Risk Factors of Dementia and Their Impact on Cognitive Function in Middle-Aged and Older Adults

Rifan Muazin May 20, 2026 0

New research from the University of California San Diego School of Medicine has revealed that women may be significantly more…

Read More
Neuroscience & Brain Research

Neurobiological Markers of Psychopathy: Study Identifies Structural Differences in the Human Striatum

Rifan Muazin May 10, 2026 0

A collaborative international research effort has uncovered a significant biological marker in the brains of individuals with psychopathic traits, potentially…

Read More
Brain Protein Menin Identified as Potential Master Regulator of Biological Aging and Cognitive HealthExplosive Growth and Early Origins of Chronic Myeloid Leukemia Revealed in Landmark Genomic StudyThis crocodile ran like a greyhound across prehistoric Britain 200 million years agoThe BioTechniques 2026 Image Competition is Now Open for Entries, Celebrating the Intersection of Scientific Innovation and Visual Art.
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ